Patent US4734412A successfully refreshed from Google Patents.
US4734412A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Medicament
Assignee: PALIZ PETER M
•
Filing: 1985-01-22
•
Granted: 1988-03-29
•
Expires: 2005-01-22
Abstract
Abstract The invention concerns a medicament that contains a combination of cinnarizine and at least one benzodiazepine compound as active principle besides usual pharmaceutical adjuvants and/or carrier substances.
Inventors
- 👤 Renate Kessler
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 15:01
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/55; A61P; A61P25/00; A61P25/20
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
38 words
A medicament, comprising besides usual pharmaceutical adjuvants and carrier substances, as the active principle, a combination of (a) at least one compound of the benzodiazepine group, and (b) cinnarizine in a weight ratio of from 1:3 to 1:50.
Claim 2
Dependent Claim
38 words
A medicament, comprising besides usual pharmaceutical adjuvants and carrier substances, as the active principle, a combination of (a) at least one compound of the benzodiazepine group, and (b) cinnarizine in a weight ratio of from 1:3 to 1:50.
Claim 3
Dependent Claim
34 words
Medicament according to claim 1, characterized in that the benzodiazepine component is selected from at least one substance selected from the group consisting of: chlordiazepoxide, diazepam, prazepam, bromazepam, clonazepam, oxazepam, nitrazepam, flurazepam and flunitrazepam.
Claim 4
Dependent Claim
26 words
Medicament according to claim 1 or 2, characterized in that it contains the benzodiazepine and the cinnarizine in a weight ratio of from 1:5 to 1:10.
Claim 5
Dependent Claim
16 words
Medicament according to claim 3, characterized in that it is formulated for oral or rectal application.
Claim 6
Dependent Claim
21 words
Medicament according to claim 3, characterized in that it contains 2 to 25 mg of the benzodiazepine component per dose unit.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-03-29 | 1991-09-28 | 1992-03-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-03-29 | 1995-09-28 | 1996-03-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-03-29 | 1999-09-28 | 2000-03-29 | $7700.00 | Window Closed / Lapsed |